Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Head and Neck Squamous Carcinoma
Interventions
DRUG

Nedaplatin

Nedaplatin is a second-generation platinum-like derivative, which is a cell cycle non-specific drug, with a mechanism of action and efficacy similar to cisplatin, and a wide anti-cancer spectrum

DRUG

Cisplatin

Cisplatin, aka cis-dichlorodiamineplatin, is a platinum-containing anticancer drug

Trial Locations (1)

550000

The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang

All Listed Sponsors
lead

Guiyang Medical University

OTHER